Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells.

Cattaneo A, Capsoni S.

Pharmacol Res. 2019 Jan;139:17-25. doi: 10.1016/j.phrs.2018.10.028. Epub 2018 Nov 1. Review.

2.

The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor.

Capsoni S, Malerba F, Carucci NM, Rizzi C, Criscuolo C, Origlia N, Calvello M, Viegi A, Meli G, Cattaneo A.

Brain. 2017 Jan;140(1):201-217. doi: 10.1093/brain/aww271.

3.

Single-Fiber Recordings of Nociceptive Fibers in Patients With HSAN Type V With Congenital Insensitivity to Pain.

Sagafos D, Kleggetveit IP, Helås T, Schmidt R, Minde J, Namer B, Schmelz M, Jørum E.

Clin J Pain. 2016 Jul;32(7):636-42. doi: 10.1097/AJP.0000000000000303.

PMID:
27270876
4.

Molecular pathogenesis, experimental therapy and genetic counseling in hereditary sensory neuropathies.

Mroczek M, Kabzińska D, Kochański A.

Acta Neurobiol Exp (Wars). 2015;75(2):126-43. Review.

5.

From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V.

Capsoni S.

Eur J Neurosci. 2014 Feb;39(3):392-400. doi: 10.1111/ejn.12461. Review.

PMID:
24494679
6.

Epidemiology of hereditary sensory and autonomic neuropathy type IV and V in Japan.

Haga N, Kubota M, Miwa Z.

Am J Med Genet A. 2013 Apr;161A(4):871-4. doi: 10.1002/ajmg.a.35803. Epub 2013 Mar 12.

PMID:
23495212
7.

Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management.

McKelvey L, Shorten GD, O'Keeffe GW.

J Neurochem. 2013 Feb;124(3):276-89. doi: 10.1111/jnc.12093. Review.

8.

Intranasal "painless" human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice.

Capsoni S, Marinelli S, Ceci M, Vignone D, Amato G, Malerba F, Paoletti F, Meli G, Viegi A, Pavone F, Cattaneo A.

PLoS One. 2012;7(5):e37555. doi: 10.1371/journal.pone.0037555. Epub 2012 May 30. Erratum in: PLoS One. 2012;7(8). doi: 10.1371/annotation/97b6c799-1ebc-4e7b-8f86-47c1130dc00e.

9.

Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity.

Capsoni S, Covaceuszach S, Marinelli S, Ceci M, Bernardo A, Minghetti L, Ugolini G, Pavone F, Cattaneo A.

PLoS One. 2011 Feb 28;6(2):e17321. doi: 10.1371/journal.pone.0017321.

10.

Reduced C-afferent fibre density affects perceived pleasantness and empathy for touch.

Morrison I, Löken LS, Minde J, Wessberg J, Perini I, Nennesmo I, Olausson H.

Brain. 2011 Apr;134(Pt 4):1116-26. doi: 10.1093/brain/awr011. Epub 2011 Mar 4.

PMID:
21378097
11.

A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy.

Carvalho OP, Thornton GK, Hertecant J, Houlden H, Nicholas AK, Cox JJ, Rielly M, Al-Gazali L, Woods CG.

J Med Genet. 2011 Feb;48(2):131-5. doi: 10.1136/jmg.2010.081455. Epub 2010 Oct 26.

12.

In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V.

Covaceuszach S, Capsoni S, Marinelli S, Pavone F, Ceci M, Ugolini G, Vignone D, Amato G, Paoletti F, Lamba D, Cattaneo A.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):824-9. doi: 10.1016/j.bbrc.2009.11.146. Epub 2009 Nov 27.

PMID:
19945432
13.

Haploinsufficiency of the nerve growth factor beta gene in a 1p13 deleted female child with an insensitivity to pain.

Fitzgibbon GJ, Kingston H, Needham M, Gaunt L.

Dev Med Child Neurol. 2009 Oct;51(10):833-7. doi: 10.1111/j.1469-8749.2008.03173.x. Epub 2008 Dec 5.

Supplemental Content

Loading ...
Support Center